Inipharm nets $35m Series A
Inipharm, a developer of therapies for liver and related diseases, has secured $35 million in Series A financing.
Inipharm, a developer of therapies for liver and related diseases, has secured $35 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination